INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

79,733 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MS
Morris SusanDirector, Chief Executive Officer
ACIAlbertsons Companies, Inc.
Grant or award
A—
336.3K sh
Apr 16, 2026Apr 20, 2026
Page 1175 of 1994
← PrevNext →
traded Apr 16, 2026
+4d
SEC Form 4

Evidence

9
MS
Mccollam SharonPresident & CFO
ACIAlbertsons Companies, Inc.
Grant or award
A—
42.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
WM
Withers MichaelEVP Retail Operations West
ACIAlbertsons Companies, Inc.
Grant or award
A—
15.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
PB
Piekos BrianChief Financial Officer
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
6,250 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
LB
Larson Robert BruceSVP & Chief Accounting Officer
ACIAlbertsons Companies, Inc.
Grant or award
A—
7,636 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
DA
Dhanda AnujChief Tech &Transformation Off
ACIAlbertsons Companies, Inc.
Grant or award
A—
88.6K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CS
Chen ShipingDirector, Chief Operating Officer
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
247.3K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
2.86M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
1,120 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,465 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CS
Chen ShipingDirector, Chief Operating Officer
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
176.2K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M—
360 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
2,001 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
BR
Backus RobertEVP Retail Operations East
ACIAlbertsons Companies, Inc.
Grant or award
A—
15.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
WM
Withers MichaelEVP Retail Operations West
ACIAlbertsons Companies, Inc.
Grant or award
A—
47.3K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
DA
Dhanda AnujChief Tech &Transformation Off
ACIAlbertsons Companies, Inc.
Grant or award
A—
29.5K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M—
270 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
KN
Krishnamurthy NikkiSVP and Chief People Officer
UBERUber Technologies, Inc
Option exercise
M—
1,322 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
LM
Larson MichelleChief Merchandising Officer
ACIAlbertsons Companies, Inc.
Grant or award
A—
35.6K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
6,250 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Option exercise
M—
232 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

9
PS
Pinkham Allison SuzanneEVP Chief HR Officer
ACIAlbertsons Companies, Inc.
Grant or award
A—
28.5K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
4,042 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
LY
Luo YulingDirector, Chief Executive Officer
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—
1.22M sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
MJ
McAnear Justin J.Chief Financial Officer
ALMRAlamar Biosciences, Inc.
Grant or award
A—
37.2K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

9
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,133 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Grant or award
A—
66.6K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
VR
Van Dyck RebeccaDirector
NYTNEW YORK TIMES CO
Grant or award
A—
151 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
MM
Moriarty Thomas MEVP, M&A and Corporate Affairs
ACIAlbertsons Companies, Inc.
Grant or award
A—
36.7K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
WM
Withers MichaelEVP Retail Operations West
ACIAlbertsons Companies, Inc.
Grant or award
A—
15.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
HJ
Hazelbaker JillSee Remarks
UBERUber Technologies, Inc
Option exercise
M—
1,493 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

9
BR
Backus RobertEVP Retail Operations East
ACIAlbertsons Companies, Inc.
Grant or award
A—
15.8K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

8
ML
Michaels Adam LauranceDirector, Chief Executive Officer
MAMAMama's Creations, Inc.
Open-market sale · 10b5-1 plan
SELL$235K
15.4K sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

8
BD
Brown Michael DeanDirector, See Remarks
TNLTravel & Leisure Co.
Open-market sale · 10b5-1 plan
SELL$88K
1,109 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC Form 4

Evidence

8
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

8
NN
Naclerio NicholasDirector
ALMRAlamar Biosciences, Inc.
Derivative conversion
C—Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC Form 4

Evidence

7
LH
Litinsky James H.Director, Chairman and CEO
MPMP Materials Corp. / DE
Open-market sale · 10b5-1 plan
SELL$2.61M
40.8K sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

7
BD
Brown Michael DeanDirector, See Remarks
TNLTravel & Leisure Co.
Option exercise · 10b5-1 plan
M—
9,443 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

7
CR
Conrad Micah R.EVP & COO
OMFOneMain Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$300K
5,000 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence

7
BD
Brown Michael DeanDirector, See Remarks
TNLTravel & Leisure Co.
Open-market sale · 10b5-1 plan
SELL$747K
9,443 sh
Apr 17, 2026Apr 20, 2026
traded Apr 17, 2026
+3dSEC Form 4

Evidence